OIV INFEKSIYASINING ZAMONAVIY EPIDEMIOLOGIK TAVSIFI VA UNING NAFAS YO‘LLARI INFEKSIYALARI BILAN BOG‘LIQLIGI
Kalit so‘zlar:
OIV, yuqori nafas yo‘llari infeksiyalari, patogenezi, sinusit, rinitAbstrak
Ushbu maqola OIV infeksiyasining hozirgi epidemiologik tavsifiga va uning yuqori nafas yo‘llari infeksiyalari (YNYI), xususan, rinit, nazofaringit, sinusit, faringit, tonzillit va laringit bilan bog‘liqligiga bag‘ishlangan. OIV infeksiyasining global miqyosda tarqalishi, shuningdek, antiretrovirus terapiya (ARVT) bilan virus yuklamasini muvaffaqiyatli bostirish OIV bilan kasallangan bemorlar orasida yuqori nafas yo‘llari infeksiyalarining keng yoyilishini istisno qilmaydi. Maqolada shuningdek, OIV infeksiyasining asosiy patogenetik mexanizmlari, xususan, immunitet tizimining zaiflashishi, mukozal immunitetning buzilishi va nafas yo‘llari infeksiyalarining rivojlanishiga kata hissa qo‘shadigan mikrobiota disbiozi ko‘rib chiqiladi. OIV bilan kasallangan bemorlar uchun profilaktika usullari, diagnostika va samarali davolash strategiyalari ham muhokama qilinadi
##plugins.themes.default.displayStats.downloads##
Havolalar
1. Skrzat-Klapaczyńska A, et al. Factors associated with the risk of upper respiratory tract bacterial infections among HIV-positive patients. PLoS ONE 17(7): e0270770. https://doi.org/10.1371/journal.pone.0270770
2. Patel S.M, et al. Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana. The Journal of Infectious Diseases, Volume 232, Issue 4, 15 October 2025, Pages 815–825, https://doi.org/10.1093/infdis/jiaf429
3. Abraham Z.S, et al. Otorhinolaryngological manifestations among people living with HIV/AIDS in Dar es Salaam, Tanzania: a cross-sectional study. Indian J Otolaryngol Head Neck Surg. 2024 Mar 14;76(4):3059–3065. doi: 10.1007/s12070-024-04598-8
4. Surdu A.E, et al. Oropharyngeal manifestations in patients with HIV from Northeastern Romania. Medicina 2025, 61(5), 855; https://doi.org/10.3390/medicina61050855
5. Piersiala K, et al. Laryngeal disorders in people living with HIV. American Journal of Otolaryngology Volume 43, Issue 1, January–February 2022
6. Shan S, et al. Clinical analysis of chronic tonsillitis in 12 HIV/AIDS patients. J Clin Otorhinolaryngol Head Neck Surg, 2017, 31(19): 1508-1511. doi: 10.13201/j.issn.1001-1781.2017.19.011
7. Essa R, et al. Tonsil histopathology in HIV-infected versus HIV-uninfected patients. Southern African Journal of HIV Medicine 20(1) May 2019
8. Fardoos R, et al. HIV specific CD8+ TRM-like cells in tonsils express exhaustive signatures in the absence of natural HIV control. Front Immunol. 2022 Oct 18:13:912038. doi: 10.3389/fimmu.2022.912038. eCollection 2022.
9. Gallego-Cortés A, et al. Identification of inducible HIV reservoirs in tonsillar tissue. 2025.
10. Ahmed N, et al. Oropharyngeal microbiome of an HIV-positive patient. 2020.
11. Ramos Peña DE, et al. Human immunodeficiency virus and oral microbiota. 2024.
12. Anshory M, et al. Transition of oral microbiome profile in HIV-infected individuals under antiretroviral therapy. 2026.
13. Narayanan A, et al. Exploring the interplay between antiretroviral therapy and oral/gut microbiota in people living with HIV. 2024.
14. Odom AR, et al. Characterization of longitudinal nasopharyngeal microbiome in HIV-exposed infants. 2024.
15. Žuštra A, et al. Longitudinal dynamics of the nasopharyngeal microbiome in women living with HIV and their children. 2025.
16. Okoror EI, et al. Respiratory viral infection and HIV viral load and CD4+ cells in HIV-infected children. 2025.
17. Lopez-Villalba B, et al. Systematic review and meta-analysis of respiratory virus infections in HIV-positive and HIV-negative patients. 2026.
18. Almeida A, et al. Respiratory Syncytial Virus among People Living with HIV. 2024.
19. Lee KW, et al. COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis. 2021.
20. Wang Y, et al. Systematic Review and Meta-Analyses of the Interaction Between HIV Infection and COVID-19. 2022.
21. Gispen F, et al. Update on Vaccination Recommendations for Adults with HIV. 2025.
22. Immunizations for Adults With HIV. NCBI Bookshelf, 2025. https://www.ncbi.nlm.nih.gov/books/
23. Immunizations for Preventable Diseases in Adults and Adolescents with HIV. Clinicalinfo HIV.gov, 2026. https://clinicalinfo.hiv.gov/
24. Cai CW, et al. Residual Immune Dysfunction Under Antiretroviral Therapy. 2021.
25. Shacklett BL. Mucosal immunity in acute HIV: a review of recent work. 2025.
26. Heron SE, et al. HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation. 2017.
27. Moir S, Fauci AS. B cell responses to HIV infection. 2017.
28. Charles TP, et al. HIV Infection and Host Defense in the Lungs. 2016.
30. Fitzpatrick ME, Kunisaki KM, Morris A. Pulmonary Disease in HIV-Infected Adults in the Era of Antiretroviral Therapy. 2018.
31. Fokkens WJ, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020 (EPOS 2020). Rhinology Supplement. 2020;29:1–464. doi: 10.4193/Rhin20.600
32. Fokkens WJ, et al. Executive summary of EPOS 2020 including integrated care pathways. Rhinology. 2020;58(2):82–111. doi: 10.4193/Rhin20.601
33. Fokkens WJ. EPOS 2020: a major step forward. Rhinology. 2020;58(1):1–2. doi: 10.4193/Rhin20.002
34. Peters AT. Rhinitis and rhinosinusitis: Literature Review 2022. 2023.
35. Romano FR, et al. Rhinosinusitis: Evidence and experience – 2024.
36. Hellings PW, et al. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care. Allergy. 2024;79(2)
37. Fokkens WJ, et al. EPOS/EUFOREA update on indication and evaluation of biologics in CRSwNP. Allergy. 2023;78(7):1680–1700. doi: 10.1111/all.15616
38. Golet M, et al. Comparison of the EPOS 2020 and POLINA 2.0 guidelines for indicating biologic treatment in adults with chronic rhinosinusitis and nasal polyps. 2025.
39. Savouré M, et al. Worldwide prevalence of rhinitis in adults: a review of definitions and prevalence. Allergy. 2022;77(7):2001–2013. doi: 10.1111/all.15255
40. Tidke M, et al. Recent Advances in Allergic Rhinitis: A Narrative Review. 2024.
41. Husna SMN, et al. Allergic Rhinitis: A Clinical and Pathophysiological Overview. 2022.
42. Brożek JL, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines revision. Journal of Allergy and Clinical Immunology. 2017;140(4):950–958. doi: 10.1016/j.jaci.2017.03.050
43. Sousa-Pinto B, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA) 2024–2025: intranasal treatment recommendations. 2025.
43. Pellegrino R, et al. Acute pharyngitis in children and adults. 2023.
44. Caldwell JM, et al. Known, Emerging, and Remerging Pharyngitis Pathogens. 2024.
45. Boyanton BL Jr, et al. Current Laboratory and Point-of-Care Pharyngitis Testing. 2024.
46. Wolford RW, et al. Pharyngitis. StatPearls, 2023. https://www.ncbi.nlm.nih.gov/books/
47. Guntinas-Lichius O, et al. Treatment of recurrent acute tonsillitis—a systematic review and clinical practice recommendations. 2023.
48. Nimmana BK, et al. Tonsillitis. StatPearls, 2025. https://www.ncbi.nlm.nih.gov/books/
49. Jacob T, et al. Antibiotics or Tonsillectomy for Adult Recurrent Tonsillitis. 2024.
50. Gupta G, et al. Acute Laryngitis. StatPearls, 2022. https://www.ncbi.nlm.nih.gov/books/
